Corporate announcement

4 months ago

LG Electronics India (LGEINDIA): Company Update

Company Update Transcript of Earnings Call Transcript of Earnings Call

Continue Reading

4 months ago

MRPL Discloses Penalty Notices from NSE and BSE Under SEBI Rule

Mangalore Refinery and Petrochemicals (MRPL) has disclosed receiving penalty notices from NSE and BSE for the quarter ending March 31, 2026, under SEBI Regulation 30.

Continue Reading

4 months ago

LG Electronics India (LGEINDIA): Company Update

Company Update Transcript of Earnings Call Transcript of Earnings Call

Continue Reading

4 months ago

LG Electronics India Announces Earnings Call Transcript via BSE Filing

LG Electronics India has filed its earnings call transcript on BSE, providing investors access to the corporate discussion and updates from the company's latest earnings review.

Continue Reading

4 months ago

LG Electronics India Files Earnings Call Transcript on BSE

LG Electronics India has filed its earnings call transcript with BSE, providing investors access to management discussion and analysis.

Continue Reading

4 months ago

LG Electronics India Files Earnings Call Transcript on BSE

LG Electronics India has submitted its earnings call transcript to the Bombay Stock Exchange, giving investors access to the detailed discussion of recent financial performance.

Continue Reading

4 months ago

LG Electronics India Releases Earnings Call Transcript | BSE Update

LG Electronics India (LGEINDIA) made a corporate announcement on BSE regarding the release of its earnings call transcript, giving investors access to the detailed quarterly discussion.

Continue Reading

4 months ago

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for the financial year, following its board meeting on May 28, 2026. The announcement was made through NSE corporate filings.

Continue Reading

4 months ago

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals Board has recommended a final dividend of Rs 1.80 per equity share for FY26, following its May 28, 2026 meeting. The proposal awaits shareholder approval.

Continue Reading

4 months ago

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend

Lincoln Pharmaceuticals Board recommends final dividend of Rs 1.80 per equity share following May 28, 2026 board meeting for shareholder approval.

Continue Reading

4 months ago

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals Limited's board has recommended a final dividend of Rs 1.80 per equity share following its meeting on May 28, 2026.

Continue Reading

4 months ago

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share following its May 28, 2026 board meeting, subject to shareholder clearance.

Continue Reading